Innovation Theater Lunch: Enhancing Skin Substitutes: Type-I Collagen Matrix for Safety and Efficacy (non-accredited/non-approved for CECH)

This innovation theater session will highlight the scientific principles behind Type-I collagen biomaterials used in skin substitutes, emphasizing how high-purity, native collagen structure and biochemical modification enhance cellular interaction, bioactivity, and tissue regeneration. It also presents clinical evidence showing improved wound-healing outcomes with advanced collagen matrices such as Helicoll, demonstrating their potential to accelerate healing and improve regenerative performance.
Sponsored by Encoll.